NIAID Begins Study of New Drug for HIV Infection
SENT BY:NIAID/OFF. of COMM. 3-22-93;12:03PM; 3014020120-h 202 408 8015 # 5 4 NAID and the Clinical Center are components of the National Institutes of Health In Bethesda, Md. NIAID supports research on allergy, immunology and Infectious diseases, including an extensive AIDS clinical research program at the Clinical Center, a 500-bed hospital on the NIH campus. I{[V.infected persons and their physicians may obtain further Information on the new BHAP trial by calling 1800-AIDS-NIH. Enrollment information for all NIAID AIDS clinical trials can be obtained by calling 1-800-TRIALS-A, Monday through Friday, 9 a.m. to 7 p.m., EST.
About this Item
- Title
- NIAID Begins Study of New Drug for HIV Infection
- Author
- National Institutes of Health (U.S.)
- Canvas
- Page 4
- Publication
- 1993-03-22
- Subject terms
- press releases
- Series/Folder Title
- Disease Management > AIDS Treatment > Pharmaceutical Treatment > General
- Item type:
- press releases
Technical Details
- Collection
- Jon Cohen AIDS Research Collection
- Link to this Item
-
https://name.umdl.umich.edu/5571095.0291.024
- Link to this scan
-
https://quod.lib.umich.edu/c/cohenaids/5571095.0291.024/4
Rights and Permissions
The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.
Related Links
IIIF
- Manifest
-
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0291.024
Cite this Item
- Full citation
-
"NIAID Begins Study of New Drug for HIV Infection." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0291.024. University of Michigan Library Digital Collections. Accessed May 10, 2025.